Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (1 ops.)
Latest filing published 01 Mar 2023 for NEW AMERICA HIGH INCOME FUND INC, €13k.
Filing timeline
BuySaleJoseph L. Bower
Insider track record
Disclosed buys
1
Disclosed sells
1
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joseph L. Bower: trading record in brief
This profile gathers the share dealings of Joseph L. Bower across 2 companies, led by Anika Therapeutics, Inc. and New America High Income Fund Inc. In total, 4 filings cover trades dated from 20 August 2019 to 27 February 2023.
The open-market side counts 1 purchase for €13k alongside 1 sale for €100k. Taken together, the sales exceed the purchases by €87k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 1 share grant. Since January 2023: 1 purchase and no sales on the market.
The record was last updated on 1 March 2023 with an open-market purchase (€13k) in New America High Income Fund Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joseph L. Bower
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,000 shares@ US$6.8099100.0% of flowCommon StockSEC:0001255647-23-000001:0
Canonical exit: 28 May 2023 (T+90)
4,107 shares0Common StockSEC:0001171843-20-001359:0
30,000 shares0Common StockSEC:0001171843-19-007869:0
1,994 shares@ US$55.57100.0% of flowCommon StockSEC:0001171843-19-005617:0
4 of 4 declarations
